Skip to main content
All lobbying filings

WESTMORELAND160, LLC

WESTMORELAND160, LLC filed a Q4 report for PHLOW CORPORATION on January 15, 2026, reporting $50,000 in lobbying income.

Lobbying for PHLOW CORPORATION · Pharmaceutical manufacturer

All filings by WESTMORELAND160, LLC · Everything PHLOW CORPORATION has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jan 15, 2026.
 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 15, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Lobbyists on this filing 1
  • WILLIAM THOMAS RICE
    Previously held: Senior Policy Advisor, Rep. David Price Military Legislative Assistant, Rep. Bud Cramer Legislative Director, Rep. Henry Bonilla Military Legislative Assistant/ Appropriations Associate, Rep. Bill Young

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Department of Defense Appropriations Act, 2026 (H.R.4016; S.2572) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2026 National Defense Authorization Act (H.R. 3838; S.2296) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2026 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act (H.R.5371)

Department of Defense Appropriations Act, 2026 (H.R.4016; S.2572) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2026 National Defense Authorization Act (H.R. 3838; S.2296) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2026 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act (H.R.5371)

 Bills named in this filing 5
  • H.R. 4016
    Department of Defense Appropriations Act, 2026
  • S. 2572
    Department of Defense Appropriations Act, 2026
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem